Literature DB >> 15723961

Endothelin, angiotensin, and oxidative stress in hypertension.

David M Pollock1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15723961     DOI： 10.1161/01.HYP.0000158262.11935.d0

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  22 in total

Review 1.  Asymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tables.

Authors:  Christopher S Wilcox
Journal:  Hypertension       Date:  2012-01-03       Impact factor: 10.190

2.  Enhanced endothelin-1 system activity with overweight and obesity.

Authors:  Brian R Weil; Christian M Westby; Gary P Van Guilder; Jared J Greiner; Brian L Stauffer; Christopher A DeSouza
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-06-10       Impact factor: 4.733

Review 3.  Newer approaches and novel drugs for inhalational therapy for pulmonary arterial hypertension.

Authors:  Ali Keshavarz; Hossam Kadry; Ahmed Alobaida; Fakhrul Ahsan
Journal:  Expert Opin Drug Deliv       Date:  2020-02-19       Impact factor: 6.648

4.  Endothelin 1-dependent neurovascular dysfunction in chronic intermittent hypoxia.

Authors:  Carmen Capone; Giuseppe Faraco; Christal Coleman; Colin N Young; Virginia M Pickel; Josef Anrather; Robin L Davisson; Costantino Iadecola
Journal:  Hypertension       Date:  2012-06-11       Impact factor: 10.190

5.  Vitamin D supplementation reduces some AT1-AA-induced downstream targets implicated in preeclampsia including hypertension.

Authors:  Jessica L Faulkner; Lorena M Amaral; Denise C Cornelius; Mark W Cunningham; Tarek Ibrahim; Autumn Heep; Nathan Campbell; Nathan Usry; Kedra Wallace; Florian Herse; Ralf Dechend; Babbette LaMarca
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2016-11-30       Impact factor: 3.619

6.  Hypertension, cardiac hypertrophy, and impaired vascular relaxation induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin are associated with increased superoxide.

Authors:  Phillip G Kopf; Janice K Huwe; Mary K Walker
Journal:  Cardiovasc Toxicol       Date:  2008-10-11       Impact factor: 3.231

7.  D3 dopamine receptor regulation of ETB receptors in renal proximal tubule cells from WKY and SHRs.

Authors:  Changqing Yu; Zhiwei Yang; Hongmei Ren; Yie Zhang; Yu Han; Duofen He; Quansheng Lu; Xiaoyan Wang; Xukai Wang; Chengming Yang; Laureano D Asico; Ulrich Hopfer; Gilbert M Eisner; Pedro A Jose; Chunyu Zeng
Journal:  Am J Hypertens       Date:  2009-04-23       Impact factor: 2.689

8.  Endothelin (ET)-1 inhibits nicotinamide adenine dinucleotide phosphate oxidase activity in human abdominal aortic endothelial cells: a novel function of ETB1 receptors.

Authors:  Jagadeesha K Dammanahalli; Zhongjie Sun
Journal:  Endocrinology       Date:  2008-06-05       Impact factor: 4.736

9.  Endothelin-1 modulates angiotensin II in the development of hypertension in fructose-fed rats.

Authors:  L T Tran; K M MacLeod; J H McNeill
Journal:  Mol Cell Biochem       Date:  2009-01-13       Impact factor: 3.396

10.  Renal D3 dopamine receptor stimulation induces natriuresis by endothelin B receptor interactions.

Authors:  Chunyu Zeng; Laureano D Asico; Changqing Yu; Van Anthony M Villar; Weibin Shi; Yingjin Luo; Zheng Wang; Duofen He; Yan Liu; Lan Huang; Chengming Yang; Xukai Wang; Ulrich Hopfer; Gilbert M Eisner; Pedro A Jose
Journal:  Kidney Int       Date:  2008-06-11       Impact factor: 10.612
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.